# Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail

> **NCT02961998** · PHASE4 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 116 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT02961998
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02961998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02961998, "Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02961998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*